1. Home
  2. STRF vs HUMAW Comparison

STRF vs HUMAW Comparison

Compare STRF & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock

STRF

MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock

HOLD

Current Price

$101.10

Market Cap

0.0

Sector

N/A

ML Signal

HOLD

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

N/A

Current Price

$0.07

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
STRF
HUMAW
Founded
N/A
2004
Country
United States
United States
Employees
1546
184
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
STRF
HUMAW
Price
$101.10
$0.07
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
80.9K
9.6K
Earning Date
N/A
03-21-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$92.00
$0.06
52 Week High
$124.24
$0.60

Technical Indicators

Market Signals
Indicator
STRF
HUMAW
Relative Strength Index (RSI) 60.65 43.99
Support Level $100.91 N/A
Resistance Level $101.20 $0.13
Average True Range (ATR) 0.80 0.01
MACD 0.03 -0.00
Stochastic Oscillator 64.29 4.82

Price Performance

Historical Comparison
STRF
HUMAW

About STRF MicroStrategy Incorporated 10.00% Series A Perpetual Strife Preferred Stock

Strategy Inc is a bitcoin treasury company and a provider of business intelligence services. It is designed to provide investors varying degrees of economic exposure to Bitcoin by offering a range of securities, including equity and fixed-income instruments. The company also provides industry AI-powered enterprise analytics software. It has one reportable operating segment: the Software Business, which is engaged in the design, development, marketing, and sales of the company's enterprise analytics software platform through cloud subscriptions and licensing arrangements and related services (i.e., product support, consulting, and education). Geographically, the company operates in EMEA, U.S. and Other Countries.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: